Comparing Gain- and Loss-Framed Messages for Smoking Cessation With Sustained-Release Bupropion: A Randomized Controlled Trial
Toll BA, O'Malley SS, Katulak NA, Wu R, Dubin JA, Latimer A, Meandzija B, George TP, Jatlow P, Cooney JL, Salovey P. Comparing Gain- and Loss-Framed Messages for Smoking Cessation With Sustained-Release Bupropion: A Randomized Controlled Trial. Psychology Of Addictive Behaviors 2007, 21: 534-544. PMID: 18072836, PMCID: PMC2527727, DOI: 10.1037/0893-164x.21.4.534.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentBupropionCommunicationDelayed-Action PreparationsDopamine Uptake InhibitorsFemaleHumansMaleSmoking CessationSmoking PreventionConceptsSustained-release bupropionSmoking cessationGain-framed messagesLoss-framed messagesTreat analysisControlled TrialsPoint prevalenceClinical trialsContinuous abstinencePrevention behaviorsTreatment completersCessationBupropionExperimental groupTrialsLoss-framed conditionHigher proportionGain-framed conditionParticipantsPrevalenceA preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain
Toll BA, Leary V, Wu R, Salovey P, Meandzija B, O'Malley SS. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain. Addictive Behaviors 2007, 33: 173-179. PMID: 17587504, PMCID: PMC2488403, DOI: 10.1016/j.addbeh.2007.05.012.Peer-Reviewed Original ResearchConceptsPost-cessation weight gainWeight-concerned smokersPoint prevalence abstinenceWeight gainAbstinent participantsSustained-release bupropion hydrochlorideHigher smoking cessation ratesWeight suppressant effectsOpen-label studyPercentage of patientsSmoking cessation ratesLess weight gainDays of treatmentNaltrexone augmentationAdverse eventsCombination pharmacotherapyPrimary outcomeCessation ratesTreatment regimenCigarette smokersClinical trialsContinuous abstinenceLabel studyPsychosocial interventionsBupropion